Excessive sugar consumption is increasingly considered as a contributor to the emerging
epidemics of obesity and the associated cardiometabolic disease. Sugar is added to the diet …

Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population and is
the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is …

New ultrasound methods that can be used to quantitatively assess liver fat content have
recently been developed. These quantitative ultrasound (QUS) methods are based on the …

Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic pathology in
industrialized countries, affecting about 25% of the general population. NAFLD is a benign …

Background The PX-104 is an oral non-steroidal agonist for the farnesoid X receptor (FXR),
a key regulator of bile acid (BA), glucose and lipid homeostasis. Aims and methods This …

The etiology of nonalcoholic fatty liver disease is complex and influenced by factors such as
obesity, insulin resistance, hyperlipidemia, and sex. We now report a study on sex difference …

The prevalence of nonalcoholic fatty liver disease has been continuously rising over the last
three decades and is projected to become the most common indication for liver …

Purpose To (a) study the optimal timing and dosing for ultrasmall superparamagnetic iron
oxide particle (USPIO)–enhanced magnetic resonance (MR) imaging of the liver in …

Hepatic steatosis is the buildup of lipids within hepatocytes. It is the simplest stage in
nonalcoholic fatty liver disease (NAFLD). It occurs in approximately 30% of the general …

Abstract Background & Aims Non‐invasive tests to diagnose non‐alcoholic steatohepatitis
(NASH) are urgently needed. This systematic review aims to evaluate imaging accuracy in …